Aytu Biopharma (AYTU) Total Liabilities (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Total Liabilities of $111.7 million for Q1 2026, down 10.07% year-over-year from $124.2 million in Q1 2025, and down 8.45% quarter-over-quarter from $122.0 million in Q4 2025.
Aytu Biopharma (AYTU) Total Liabilities (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Total Liabilities for 16 consecutive years, with $111.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 10.07% year-over-year to $111.7 million; the TTM figure through Mar 2026 stood at $111.7 million (down 10.07% YoY), while the FY2025 annual figure was $124.2 million, up 5.15% from the prior year.
- Total Liabilities eased to $111.7 million in Q1 2026 per AYTU's latest filing, from $122.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $131.2 million in Q4 2023 and bottomed at $93.3 million in Q2 2022.
- Historically, Total Liabilities has averaged $112.9 million across 5 years, with a median of $115.8 million in 2024.
- On a YoY basis, Total Liabilities climbed as much as 72169.8% in 2022 and fell as far as 27.15% in 2022.
- Aytu Biopharma's Total Liabilities stood at $95.6 million in 2022, then jumped by 37.26% to $131.2 million in 2023, then retreated by 11.45% to $116.2 million in 2024, then advanced by 4.97% to $122.0 million in 2025, then retreated by 8.45% to $111.7 million in 2026.
- Business Quant data shows AYTU's Total Liabilities at $111.7 million in Q1 2026, $122.0 million in Q4 2025, and $125.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Aytu Biopharma | 23.86 Mn | -2.85 Mn | 7.60 Mn | 111.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.69 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Sep 30, 2025 | 124.99 Mn |
| Jun 30, 2025 | 124.18 Mn |
| Mar 31, 2025 | 124.20 Mn |
| Dec 31, 2024 | 116.23 Mn |
| Sep 30, 2024 | 115.83 Mn |
| Jun 30, 2024 | 118.10 Mn |
| Mar 31, 2024 | 128.86 Mn |
| Dec 31, 2023 | 131.25 Mn |
| Sep 30, 2023 | 100.72 Mn |
| Jun 30, 2023 | 97.11 Mn |
| Mar 31, 2023 | 106.30 Mn |
| Dec 31, 2022 | 95.62 Mn |
| Sep 30, 2022 | 101.65 Mn |
| Jun 30, 2022 | 93.32 Mn |
| Mar 31, 2022 | 107.68 Mn |
| Dec 31, 2021 | 118.29 Mn |
| Sep 30, 2021 | 116.23 Mn |
| Jun 30, 2021 | 128.10 Mn |